Bodal Chemicals · NSE: BODALCHEM · BSE: 524370
Q1 FY25 results · Apr–Jun 2024
Bodal Chemicals reported revenue from operations of ₹421.96 crore (up 26.9% from Q1 FY24) and net loss of ₹1.18 crore for Q1 FY25 (Apr–Jun 2024), on a consolidated basis.
| Item | Q1 FY25 | Q1 FY24 | YoY | Q4 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 421.96 | 332.49 | +26.9% | 393.59 | +7.2% |
| Other income | 2.46 | 8.78 | −71.9% | 5.45 | −54.8% |
| Total income | 424.43 | 341.26 | +24.4% | 399.03 | +6.4% |
| Profit before tax | (1.45) | 3.19 | Turned loss | (2.06) | Loss narrowed |
| Net profit for the period | (1.18) | 2.21 | Turned loss | 2.04 | Turned loss |
| EPS, basic (₹) | (0.09) | 0.18 | Turned loss | 0.16 | Turned loss |
| Net margin (%) | -0.3 | 0.7 | 0.5 |
| Item | Q1 FY25 | Q1 FY24 | YoY | Q4 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 420.20 | 325.75 | +29.0% | 395.52 | +6.2% |
| Other income | 1.20 | 3.65 | −67.2% | 1.17 | +2.3% |
| Total income | 421.40 | 329.40 | +27.9% | 396.69 | +6.2% |
| Profit before tax | 1.52 | 1.44 | +5.6% | 7.02 | −78.3% |
| Net profit for the period | 1.14 | 1.07 | +6.3% | 4.91 | −76.8% |
| EPS, basic (₹) | 0.09 | 0.09 | +0.0% | 0.39 | −76.9% |
| Net margin (%) | 0.3 | 0.3 | 1.2 |
Consolidated
- Filed with BSE
- 29 Aug 2024, 11:16 IST
- Board meeting
- 14 Aug 2024
- Period
- 01 Apr 2024 to 30 Jun 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 29 Aug 2024, 11:16 IST
- Board meeting
- 14 Aug 2024
- Period
- 01 Apr 2024 to 30 Jun 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE